U.S. Antiplatelet Market

U.S. Antiplatelet Market

 

RELEASE DATE
28-Jun-2006
REGION
North America
Research Code: F804-01-00-00-00
SKU: HC01527-NA-MR_06107
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01527-NA-MR_06107

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service analyzes the changing dynamics in the U.S. antiplatelet market for the period 2002-2012. Included are a pipeline analysis, and revenue forecasts for the segments and total market, as well as selected major products. Both products currently in the market, as well as those forecast to enter the market by 2012 are included, with an emphasis on branded drug products. The market is segmented by delivery: oral and injectable. The products covered in this research service are used in the treatment of diseases such as acute coronary syndromes, and stroke.

Table of Contents

Executive Summary

  • Introduction

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Market Overview

  • Introduction
  • Disease Overview
  • Platelets
  • Market Engineering Measurements
  • Industry Issues And Challenges
  • Market Drivers
  • Market Restraints

Competitive Analysis

Revenue Forecasts

  • Competitive Structure
  • Product Analysis - ADP Antagonists
  • Product Analysis - Adenosine Reuptake Inhibitors
  • Product Analysis - Glycoprotein IIb/IIIa Inhibitors
  • Pipeline Analysis

Market Share Analysis

  • Injectable Revenue Forecasts
  • Oral Revenue Forecasts
  • Total Antiplatelet Market Forecast

Decision Support Databases

This research service analyzes the changing dynamics in the U.S. antiplatelet market for the period 2002-2012. Included are a pipeline analysis, and revenue forecasts for the segments and total market, as well as selected major products. Both products currently in the market, as well as those forecast to enter the market by 2012 are included, with an emphasis on branded drug products. The market is segmented by delivery: oral and injectable. The products covered in this research service are used in the treatment of diseases such as acute coronary syndromes, and stroke.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number F804-01-00-00-00
Is Prebook No